Researchers sought to determine whether it would be beneficial to add inotuzumab to the CALGB 10403 pediatric regimen in the treatment of young adults with CD22-positive B-ALL.

Teclistamab maintenance, given alone or in combination with lenalidomide, appeared to be safe and demonstrated “unprecedented efficacy” in patients with multiple myeloma in the phase 3 MajesTEC-4 ...

Revumenib, venetoclax, and ASTX727 (a fixed-dose combination of decitabine and cedazuridine) demonstrated efficacy in patients with relapsed or refractory AML.

Adding blinatumomab to chemotherapy improved disease-free survival in children with NCI standard-risk B-cell ALL.

A prospective, longitudinal study sought to determine the effects of nutrition status, daily habits, and sleep pattern on length of stay in patients with ovarian cancer undergoing chemotherapy.

Metformin may improve lung cancer-specific clinical outcomes in obese and overweight lung cancer patients and enhance immunotherapy efficacy in this growing population as well,” researchers concluded.

Subsequent leukemia was associated with high cumulative doses of epipodophyllotoxins, older age at initial cancer diagnosis, and receipt of hematopoietic stem cell transplant.

Strategies nurses and other healthcare professionals can use to help patients with cancer cope with anxiety in inpatient and outpatient settings.

Researchers surveyed nurses at EBMT centers to explore their training needs relating to ATMPs, local procedures, and self-assessed priority ranking for ATMP training.

Patients with a negative colonoscopy result had a “persistently lower” risk of colorectal cancer incidence and death for at least 20 years, researchers found.

Researchers assessed the link between arterial thrombosis incidence and the risk of developing second cancers in patients with MPNs.

Highest association seen at five-year lag period, but significant associations also seen at no lag, up to 20-year lag period.